Spectral Medical Inc T.EDT

No volume and no liquidity

[numb3r]

The problem here is that there are very few shares that could be bought and volume is always low so it's hard to trade, someone needs to release a few million shares just to add liquidity here then you might have healthier trading stock.

[hmmmmmmmm]

Ha. Dig a little deeper. There are almost 300 million shares. Plenty of shares- investors aren't selling them for a reason.

[mercedesman]

Releasing a few million shares on the sell side will do nothing except create downward pricing pressure.  Needs wider promotion and coverage at the same time, in order to create demand & volume ... Easily done given count down to FDA, BTD, recent SAMI sales, involvement of major players, Trial results, and ongoing paradigm shift to HHD... but..,then again... ... shining a light on

[TechOne]

This is not a trading stock as far as it goes..  Investing here/buying shares in Spectral is akin to putting your money on the routette wheel spinnig..  One of these days, it will stop spinning and whether we collect a big hefty payout or not is the question.. :) FWIW .. 

[Gorf79]

With the now commercial Dialco division landing massive deals in ARC Dialysis and the  Department  of Veterans Affairs it should be a $3.00 minimum value on those deals alone. Having said that they do wear the crapshoot handle well. Really well! At 10 plus years with the same share price and IR company representing them  you could say they want to appear as a roulette spin

[mercedesman]

With Tigris results " greatly exceeding expectations" in a Phase 3 " Confirmatory" Trial and with DIMI approval " a when not if" event, and with the EAA ( the key to solving the Sepsis cunnundrum, see precision Medicine) already FDA approved, and with SAMI closing some big deals with key customers, and already FDA approved, and with mounting real world evidence on PMX

[jdunlop]

No roulette wheel here. Spectral are holding a royal flush.

[Geery]

Products/solutions seem great. Company/management is the roulette component. That is probably where Tech is highlighting.  On the surface it looks like a no brainer. Internally I have no clue and very little confidence. Management have yet to prove themselves for my liking. There have been more positives lately but I just keep waiting for the next negative.   

[Gorf79]

The next negative?  It could be that Infomed production, while fully geared up for Dialco's US market initiatives, can't meet the unexpected demand of the initial ARC and Veterans Affairs orders. Those now forgotten and washed through deals did look rather significant when announced. Worthless now though... If they leave that other shoe ready to drop long enough, and make no effort

[mercedesman]

Point earned and taken Geery. Hopefully Seto has been cooking up something behind the scenes that is more creative, less dilutive, and doesn't reward non-performing parties like Paradigm or an opportunistic investor "in it" for the warrant play only. The BoD has entrusted him to bring it home.  Let's hope he doesn't mess it up.  Some believe that any "dog

[TechOne]

Sure..  Odds are better for Spectral in round 2..  Because of Dialco, sum of the parts is a lot higher then the current market cap..  No longer a 1 tricke poney and I give full marks to the management for reducing the risk... With Phase III trial, once again because it is an open trial and FDA has given them all types of breaks to make it a success so hopefully, there won't a